Portable chest X-ray screening to rapidly find TB in migrants

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

SPOT-TB tests a mobile, AI-assisted TB screening approach in a migrant population in NYC. The program combines ultra-portable digital chest radiography, AI interpretation, symptom checks, latent TB testing, and HIV testing to flag concerning results for clinical follow-up. The study aims to measure feasibility, acceptability, and how well the approach improves early TB identification and linkage to care in community settings. It also aims to describe the prevalence of TB and latent TB infection in this population and how mobile AI-assisted screening can be implemented in a real-world context.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult persons 18 years or older
* Self-identifying as migrants to the US
* Self-reporting migration within the 24 months

Exclusion Criteria:

* Lack capacity for informed consent
* Unable to perform translation/study materials not available in appropriate language
* Unwilling to participate
* Prisoner
* Pregnancy

Where it's running

• African Services Committee
  New York, New York, United States Recruiting

Study contacts

• Study coordinator: Allison Wolf, MPH
• Email: aw2565@cumc.columbia.edu
• Phone: 212-342-44'1

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Reexamining how asymptomatic tuberculosis spreads

  This project will test whether people with asymptomatic tuberculosis—particularly adults living with HIV—can pass TB to their household and close contacts.

  Recruiting Barcelona Institute for Global Health · Manhiça, Maputo Province · NCT07312266

• Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide

  This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.

  Recruiting Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida · Paris · NCT07921472

• Multiple interventions to try for HIV remission in people on ART

  This study tests a combination approach, including intensified ART, latency-reversal agents, and autologous dendritic cell therapy, to see if people living with HIV on long-term ART can achieve sustained viral suppression or prolonged remission.

  Recruiting Phase 2 Federal University of São Paulo · São Paulo, São Paulo · NCT07903441

• Preventive TB treatment for freshmen with strong TB skin tests

  This study tests whether a short course of preventive TB treatment given to freshmen with strong TB skin tests can reduce the chance of developing active TB over 3 to 4 years.

  Recruiting at 2 sites Phase 4 Affiliated Hospital of Nantong University · Nantong, Jiangsu and 1 other locations · NCT07811518

• Two-probe thermal ablation for cervical precancer in WLWH in South Africa

  This study tests whether using two probes for thermal ablation is safer or more effective than one probe for treating cervical precancer in women living with HIV in South Africa.

  Recruiting Fred Hutchinson Cancer Center · Durban · NCT07645378

• Two-probe thermal ablation for cervical precancer in WLWH in Zimbabwe

  This study tests whether using two TA probes (endocervical and ectocervical) is better than one probe for treating cervical precancer in women living with HIV in Zimbabwe.

  Recruiting Fred Hutchinson Cancer Center · Harare · NCT07645352

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.